These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 9163793)

  • 1. Advanced glycosylation end products in peritoneal tissue with different solutions.
    Dobbie JW
    Perit Dial Int; 1997; 17 Suppl 2():S27-30. PubMed ID: 9163793
    [No Abstract]   [Full Text] [Related]  

  • 2. AGE accumulation in peritoneal membrane and cavity during peritoneal dialysis and its effect on peritoneal structure and function.
    Park MS; Lee HB
    Perit Dial Int; 1999; 19 Suppl 2():S53-7. PubMed ID: 10406494
    [No Abstract]   [Full Text] [Related]  

  • 3. A food chemist's view of advanced glycation end-products.
    Henle T
    Perit Dial Int; 2001; 21 Suppl 3():S125-30. PubMed ID: 11887806
    [No Abstract]   [Full Text] [Related]  

  • 4. Peritoneal dialysis in diabetic patients.
    Bertoli M; Bonfante L; Gambaro G; Cara M; Virgilio B; D'Angelo A
    Contrib Nephrol; 2001; (131):51-60. PubMed ID: 11125563
    [No Abstract]   [Full Text] [Related]  

  • 5. Peritoneal transport in long-term peritoneal dialysis patients and its relation with AGEs.
    Feriani M
    Contrib Nephrol; 2001; (131):74-81. PubMed ID: 11125565
    [No Abstract]   [Full Text] [Related]  

  • 6. Advanced glycation end products in peritoneal dialysis.
    Dawnay A
    Perit Dial Int; 1996; 16 Suppl 1():S50-3. PubMed ID: 8728162
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro formation of advanced glycation end products in peritoneal dialysis fluid.
    Lamb EJ; Cattell WR; Dawnay AB
    Kidney Int; 1995 Jun; 47(6):1768-74. PubMed ID: 7643548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycation and advanced glycation end-product formation with icodextrin and dextrose.
    Dawnay AB; Millar DJ
    Perit Dial Int; 1997; 17(1):52-8. PubMed ID: 9068023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of transforming growth factor-beta 1 gene overexpression as a strategy to prevent fibrosis.
    Gambaro G; Weigert C; Ceol M; Schleicher ED
    Contrib Nephrol; 2001; (131):107-13. PubMed ID: 11125556
    [No Abstract]   [Full Text] [Related]  

  • 10. The John F. Maher Recipient Lecture 2004: Rage in the peritoneum.
    De Vriese AS
    Perit Dial Int; 2005; 25(1):8-11. PubMed ID: 15770917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategy for preventing peritoneal dialysis failure.
    Cancarini G
    Contrib Nephrol; 2001; (131):114-24. PubMed ID: 11125557
    [No Abstract]   [Full Text] [Related]  

  • 12. Benfotiamine protects against peritoneal and kidney damage in peritoneal dialysis.
    Kihm LP; Müller-Krebs S; Klein J; Ehrlich G; Mertes L; Gross ML; Adaikalakoteswari A; Thornalley PJ; Hammes HP; Nawroth PP; Zeier M; Schwenger V
    J Am Soc Nephrol; 2011 May; 22(5):914-26. PubMed ID: 21511829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can biocompatible dialysis fluids improve outcomes in peritoneal dialysis patients?
    Woodrow G
    Perit Dial Int; 2005; 25(3):230-3. PubMed ID: 15981769
    [No Abstract]   [Full Text] [Related]  

  • 14. Advanced glycosylation end-products in diabetic rats on peritoneal dialysis using various solutions.
    Lee JH; Reddy DK; Saran R; Moore HL; Twardowski ZJ; Nolph KD; Khanna R
    Perit Dial Int; 2000; 20(6):643-51. PubMed ID: 11216553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GDP and AGE receptors: mechanisms of peritoneal damage.
    Schwenger V
    Contrib Nephrol; 2006; 150():77-83. PubMed ID: 16720995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peritoneal dialysis in diabetic patients.
    Lee HB; Chung SH; Chu WS; Kim JK; Ha H
    Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S200-3. PubMed ID: 11576955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular biology of the peritoneal membrane: in between morphology and function.
    Anglani F; Forino M; Del Prete D; Ceol M; Favaro S
    Contrib Nephrol; 2001; (131):61-73. PubMed ID: 11125564
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of bicarbonate/lactate solution on peritoneal advanced glycosylation end-product accumulation.
    Park MS; Kim JK; Holmes C; Weiss MF
    Perit Dial Int; 2000; 20 Suppl 5():S33-8. PubMed ID: 11229610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetic nephropathy and advanced glycation end products.
    Menè P; Festuccia F; Polci R; Pugliese F; Cinotti GA
    Contrib Nephrol; 2001; (131):22-32. PubMed ID: 11125560
    [No Abstract]   [Full Text] [Related]  

  • 20. Low glucose degradation product peritoneal dialysis regimen is associated with lower plasma EN-RAGE and HMGB-1 proinflammatory ligands of receptor for advanced glycation end products.
    Opatrna S; Popperlova A; Kalousová M; Zima T
    Ther Apher Dial; 2014 Jun; 18(3):309-16. PubMed ID: 24965297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.